Earnings History Data for Finch Therapeutics Group, Inc. (FNCH) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Finch Therapeutics Group, Inc.

Finch Therapeutics Group Inc. is a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery(R) platform to develop a novel class of orally administered biological drugs. The company's product candidate includes CP101, FIN-211, FIN-524 and FIN-525. Finch Therapeutics Group Inc. is based in SOMERVILLE, Mass.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
10-11-2022 PM 7:00 AM ET
(Nov 10)
FNCH Finch Therapeutics Group, Inc. 60.09 -0.45 -0.40 -0.21 Finch Therapeutics GAAP EPS of -$0.85 misses by $0.45
[11/10/2022 9:20 AM]
1.07 0.05 
(4.39%)
1.00 -0.03 
(-2.44%)
1.01 - 17.39 50,458 50,000 217
11-08-2022 PM FNCH Finch Therapeutics Group 117.00 -0.48 -0.46 0.00 Finch Therapeutics GAAP EPS of -$0.48 misses by $0.07, revenue of $0.36M
[8/11/2022 9:09 AM]
2.63 0.03 
(1.15%)
2.60 0.0 
(0.00%)
1.71 - 17.39 47,302 50,000 1,587
16-05-2022 PM FNCH Finch Therapeutics Group, Inc. 96.54 -0.52 0.00 1.00 Finch Therapeutics GAAP EPS of -$0.52, revenue of $0.35M
[5/16/2022 9:39 AM]
2.12 -0.11 
(-4.93%)
2.31 0.08 
(3.59%)
1.71 - 22.10 185,488 510,000 2,872
31-03-2022 AH After the close
(Mar 31)
FNCH Finch Therapeutics Group, Inc. 244.52 -0.40 -0.42 0.00 Finch Therapeutics GAAP EPS of -$0.40, revenue of $0.8M
[3/31/2022 5:22 PM]
4.78 -0.25 
(-4.97%)
5.02 0.0 
(0.00%)
4.52 - 22.10 57,058 40,000 203
10-11-2021 PM FNCH Finch Therapeutics Group, Inc. 663.81 -0.21 -0.42 0.00 Finch Therapeutics EPS beats by $0.07
[11/10/2021 9:05 AM]
14.44 -0.34 
(-2.30%)
15.51 0.73 
(4.94%)
11.56 - 22.50 83,359 100,000 2,425
10-08-2021 PM FNCH Finch Therapeutics Group, Inc. 654.00 -0.32 -0.28 0.00 Finch Therapeutics EPS misses by $0.04
[8/10/2021 7:38 AM]
14.00 0.21 
(1.52%)
0.0 0.0 
(0.00%)
11.56 - 22.50 24,404 20,000 0